Pandey, A. 2025. HBV Pre-S Mutants and Hepatocellular Carcinoma: New Molecular Pathways, Clinical Implications, and Therapeutic Horizons (2020–2025). Journal of Emerging Pharmaceutical and Medical Research (JEPMR). 1, 2 (Aug. 2025), 87–126.